Mar 27, 2024 (Nanowerk Information) Purdue College researchers are growing and validating patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to reinforce immunotherapy results in opposition to malignant tumors. The nanoparticles slowly launch medication that induce immunogenic cell demise, or ICD, in tumors. ICD generates tumor antigens and different molecules